|Last Price$78.42||Day Change (%)1.34%|
|Open Price$78.24||Day Change ($)1.04|
|Day Range77.70–78.45||52-Week Range55.85–79.50|
As of Mon 3/30/2015 6:03:00 PM | USD
Medtronic Files 8K - Regulation FD
Ladies and gentlemen, thank you for standing by, and welcome to the Medtronic Fourth Quarter Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. Thank you.
The device maker's planned acquisition of Covidien will make it a force to be reckoned with.
The firm is on track to meet our full-year estimates, and our $60 per share fair value estimate and wide moat rating are intact.
NuVasive: Court Overturns $102 Million Award to Medtronic --Update
NuVasive: Court Overturns $102 Million Award to Medtronic
Research and Markets: MediPoint: Coronary Stents - South America Analysis and Market Forecasts to 2020
Research and Markets: MediPoint: Craniomaxillofacial Devices - 5EU Analysis and Market Forecasts
Research and Markets: India Coronary Stents Market - Potential & Growth Forecast to 2019
Research and Markets: Australia Orthopedic Devices Market Assessment and Forecasts To 2020